- Previous Close
9,550.00 - Open
9,450.00 - Bid 9,630.00 x --
- Ask 9,640.00 x --
- Day's Range
9,250.00 - 9,660.00 - 52 Week Range
6,650.00 - 11,770.00 - Volume
56,379 - Avg. Volume
65,016 - Market Cap (intraday)
170.826B - Beta (5Y Monthly) 0.21
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 200.00 (1.89%)
- Ex-Dividend Date Dec 27, 2023
- 1y Target Est
--
NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Korea.
www.novarex.co.kr408
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 194700.KQ
View MorePerformance Overview: 194700.KQ
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 194700.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 194700.KQ
View MoreValuation Measures
Market Cap
169.06B
Enterprise Value
162.47B
Trailing P/E
7.35
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.57
Price/Book (mrq)
0.77
Enterprise Value/Revenue
0.55
Enterprise Value/EBITDA
4.19
Financial Highlights
Profitability and Income Statement
Profit Margin
7.42%
Return on Assets (ttm)
5.57%
Return on Equity (ttm)
11.26%
Revenue (ttm)
289.46B
Net Income Avi to Common (ttm)
21.48B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
26.64B
Total Debt/Equity (mrq)
8.94%
Levered Free Cash Flow (ttm)
6.4B